Clinical Explorative Optical Breast Investigations

Launched by REGION SKANE · Feb 27, 2025

Keywords

ClinConnect Summary

The Clinical Explorative Optical Breast Investigations trial is studying new ways to tell the difference between healthy breast tissue, benign (non-cancerous) tumors, and malignant (cancerous) tumors. Researchers want to use special techniques called diffuse reflectance spectroscopy and photoacoustic imaging, which look at the light properties of breast tissue, to help make these distinctions. This could potentially improve how breast conditions are diagnosed.

To participate in the trial, women aged 65 to 74 who have a single tumor that is larger than 1 cm and has been confirmed to be either benign or malignant by a biopsy may be eligible. Participants should be able to understand both written and spoken Swedish. However, those who have had previous breast surgery, received chemotherapy before surgery, or have skin burns on their chest cannot take part. If eligible, participants can expect to undergo the new imaging tests, which are designed to provide important information about their breast condition while contributing to future breast cancer research.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • solitary malignant or benign biopsy verified tumour \> 1 cm
• • understands written and oral Swedish
• Exclusion Criteria:
• • previous breast surgery
• • has received neoadjuvant chemotherapy
• • skin burns in on the chest